REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients "REGENESIS"

Withdrawn

Phase 2 Results N/A

Main Contacts

Name Phone E-mail
Steven C Cramer, MD, MMSc Principal Investigator

Other Locations

Name City State Country Status
Hoag Memorial Hospital Presbyterian Newport Beach California United States Unknown_status_icon
University of California, Irvine Medical Center Orange California United States Unknown_status_icon